Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
program during the postdoctoral training. Requirements: We are looking for an enthusiastic scientist with a desire to work on a challenging and timely project using state of the art technology as part of a
-
(independently and in our team) involvement in teaching across different life science study programs at the Faculty of Medicine Required skills: Ph.D. (or comparable) in Bioinformatics, Computational Biology
-
from over 50 nations, it is the largest institute of the Max Planck Society. The Department of Theoretical and Computational Biophysics headed by Helmut Grubmüller is inviting applications for a PhD
-
derived from the host, the diet or the microbiome shape the biology and metabolism of tissue-resident immune cells (e.g. T cells, innate lymphoid cells (ILC)) in health and disease. In particular the work
-
Bioprogrammable Materials is looking for an enthusiastic Post-doctoral Researcher with experience in Protein Engineering. We combine synthetic biology and biomaterials to develop smart platforms for therapeutics
-
prostate tumor samples. This position requires a strong background in both experimental proteomics and computational data science (R and Python), with an emphasis on LC-MS/MS workflows and long-term cohort
-
possible date at the KlausTschira Institute for Integrative Computational Cardiology to join our interdisciplinary project at the forefront of RNA biology and sequencing technology. Project Overview
-
field Strong publication record and experience in basic science or translational research Background in molecular oncology, tumor biology, liver-focused or immune-focused research, or computational
-
species Perform bioinformatics and computational analyses to identify microbiome-lifespan relationships Apply rigorous molecular biology methodologies to elucidate mechanisms underlying microbiome effects
-
researcher (m/f/d) (biology, biochemistry, biotechnology or related areas) Our project investigates the mechanisms of inherited bone marrow failure and its progression into hematological malignancies. Our